{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01343511",
      "OrgStudyIdInfo": {
        "OrgStudyId": "BKCR-AUTISM-1.0(2009)"
      },
      "Organization": {
        "OrgFullName": "Shenzhen Beike Bio-Technology Co., Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Safety and Efficacy of Stem Cell Therapy in Patients With Autism",
      "OfficialTitle": "Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2011",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2009"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 2010",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 2011",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 26, 2011",
      "StudyFirstSubmitQCDate": "April 26, 2011",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 28, 2011",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "October 13, 2011",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 14, 2011",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Shenzhen Beike Bio-Technology Co., Ltd.",
        "LeadSponsorClass": "INDUSTRY"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Shandong Jiaotong Hospital",
            "CollaboratorClass": "UNKNOWN"
          },
          {
            "CollaboratorName": "Association for the Handicapped Of Jinan",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Autism is one of those disorders in Autism spectrum disorders (ASD), which characterized by social interaction abnormalities, impaired verbal and non-verbal communication, and repetitive, obsessive behavior, while the therapeutic effect of current treatments remains limited progress .Neural hypoperfusion and immune deregulation are the two key pathologies associated with Autism. Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and enhance angiogenesis, suggesting the novel and promising therapeutic strategy. In this study, the safety and efficacy of hUC-MSCs and hCB-MNCs transplantation will be evaluated in patients with Autism.",
      "DetailedDescription": "To investigate the safety and efficacy of human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells transplantation in patients of Autism."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Autism"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Autism",
          "human cord blood mononuclear cells",
          "human umbilical cord mesenchymal stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "37",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Rehabilitation plus hCB-MNCs treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will be given rehabilitation therapy plus human cord blood mononuclear cells transplantation with a 6 months follow-up.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: human cord blood mononuclear cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Rehabilitation plus hCB-MNCs and hUC-MSCs therapy",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants will be given rehabilitation therapy plus combination of hCB-MNCs together with hUC-MSCs transplantation with a 6 months follow-up.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "human cord blood mononuclear cells",
            "InterventionDescription": "Participants will be given rehabilitation therapy plus hCB-MNCs transplantation.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Rehabilitation plus hCB-MNCs treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Group 1"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells",
            "InterventionDescription": "Participants will be given rehabilitation therapy plus and hCB-MNCs and hUC-MSCs transplantation.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Rehabilitation plus hCB-MNCs and hUC-MSCs therapy"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Group 2"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Childhood Autism Rating Scale，CARS",
            "PrimaryOutcomeTimeFrame": "6 months after treatment"
          },
          {
            "PrimaryOutcomeMeasure": "Clinical Global Impression Scale，CGI",
            "PrimaryOutcomeTimeFrame": "6 months after treatment"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Aberrant Behavior Checklist，ABC",
            "SecondaryOutcomeTimeFrame": "6 months after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "Adverse Event and Serious Adverse Event",
            "SecondaryOutcomeTimeFrame": "6 months after treatment"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nChildren between the ages of 3 and 12 years.\nDSM-IV diagnosis of Autistic Disorder.\nTotal score of CARS ≥ 30.\nParents or legal guardian willing to sign the ICF.\n\nExclusion Criteria:\n\nAny history of hypersensitivity to serum products, or other known drug and food allergy.\nHistory of prior or current DSM-IV psychotic disorder (e.g., schizophrenia, bipolar disorder, other psychosis), Pervasive Developmental Disorder not otherwise specified (PDD NOS), Asperger's, or Rett's.\nHistory of Epileptic seizure activity in the past 6 months.\nAutism caused by seizure disorders (active), cerebrovascular disease or brain trauma.\nThe global autism ratings are assessed as being absent, minimal or mild.\nExisting moderate or severe extrapyramidal symptoms (EPS) or history of tardive dyskinesia.\nSubjects who have displayed significant self-injurious behavior (children who have caused visible harm to themselves).\nHIV+\nAcute and chronic hepatitis.\nAutoimmune disease, e.g. lupus erythematosus, multiple sclerosis.\nSevere pulmonary and hematological disease, malignancy or hypo-immunity.\nCurrently undertaking other treatment that may affect the safety/efficacy of stem cells.\nEnrollment in other trials in the last 3 months.\nOther criteria the investigator consider improper for inclusion.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "3 Years",
      "MaximumAge": "12 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Yongtao Lv",
            "OverallOfficialAffiliation": "Shandong Jiaotong Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Shandong Jiaotong Hospital",
            "LocationCity": "Jinan",
            "LocationState": "Shandong",
            "LocationZip": "250031",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferenceType": "result",
            "ReferenceCitation": "Liu M, Sun LW, LV YT, Huan Y, Ge RC, Cao YL, Guo CQ, Chen XW. Stem cells for treatment of autism: Safety and efficacy. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2010;14(32): 5967-5970."
          },
          {
            "ReferencePMID": "23978163",
            "ReferenceType": "derived",
            "ReferenceCitation": "Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, Huan Y, Ge RC, Chen XW, Wang ZJ, Kim BJ, Hu X. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med. 2013 Aug 27;11:196. doi: 10.1186/1479-5876-11-196."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000001321",
            "ConditionMeshTerm": "Autistic Disorder"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000067877",
            "ConditionAncestorTerm": "Autism Spectrum Disorder"
          },
          {
            "ConditionAncestorId": "D000002659",
            "ConditionAncestorTerm": "Child Development Disorders, Pervasive"
          },
          {
            "ConditionAncestorId": "D000065886",
            "ConditionAncestorTerm": "Neurodevelopmental Disorders"
          },
          {
            "ConditionAncestorId": "D000001523",
            "ConditionAncestorTerm": "Mental Disorders"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M3775",
            "ConditionBrowseLeafName": "Autistic Disorder",
            "ConditionBrowseLeafAsFound": "Autism",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M206",
            "ConditionBrowseLeafName": "Autism Spectrum Disorder",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5055",
            "ConditionBrowseLeafName": "Child Development Disorders, Pervasive",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5054",
            "ConditionBrowseLeafName": "Developmental Disabilities",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M29797",
            "ConditionBrowseLeafName": "Neurodevelopmental Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M3967",
            "ConditionBrowseLeafName": "Mental Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13625",
            "ConditionBrowseLeafName": "Psychotic Disorders",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXM",
            "ConditionBrowseBranchName": "Behaviors and Mental Disorders"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}